{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:05:40Z","timestamp":1792242340534,"version":"4.4.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.xphs.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T11:42:59Z","timestamp":1523706179000},"page":"2119-2127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Superparamagnetic Iron Oxide\u2013Loaded Lipid Nanocarriers Incorporated in Thermosensitive In Situ Gel for Magnetic Brain Targeting of Clonazepam"],"prefix":"10.1016","volume":"107","author":[{"given":"Haidy","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Refai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"El Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.04.007_bib1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.wnl.0000252807.38124.a3","article-title":"How common are the \u201ccommon\u201d neurologic disorders?","volume":"68","author":"Hirtz","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.xphs.2018.04.007_bib2","first-page":"451","article-title":"Antimanic effect of clonazepam","volume":"18","author":"Chouinard","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.xphs.2018.04.007_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.forsciint.2008.12.004","article-title":"Blood concentrations of clonazepam and 7-aminoclonazepam in forensic cases in Denmark for the period 2002\u20132007","volume":"184","author":"Steentoft","year":"2009","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.xphs.2018.04.007_bib4","first-page":"1","article-title":"Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability","volume":"42 Suppl 1","author":"Alvarez","year":"1998","journal-title":"J\u00a0Intellect Disabil Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A\u00a0theoretical basis for a biopharmaceutic drug classification: the correlation of in\u00a0vitro drug product dissolution and in\u00a0vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0378-5173(01)00806-7","article-title":"Evaluation of in\u00a0vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations","volume":"228","author":"Puglia","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/jps.20480","article-title":"Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting","volume":"95","author":"Vyas","year":"2006","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib8","first-page":"715","article-title":"Brain-targeted nasal clonazepam microspheres","volume":"71","author":"Shaji","year":"2009","journal-title":"Indian J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib9","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1080\/10717544.2016.1223216","article-title":"Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in\u00a0vitro optimization, ex\u00a0vivo determination of cytotoxicity, in\u00a0vivo biodistribution and pharmacodynamics studies","volume":"23","author":"Nour","year":"2016","journal-title":"Drug Deliv"},{"issue":"2","key":"10.1016\/j.xphs.2018.04.007_bib10","first-page":"1","article-title":"Transferosomes for trans-nasal brain delivery of clonazepam: preparation, optimization, ex-vivo cytotoxicity and pharmacodynamic study","volume":"1","author":"Nour","year":"2017","journal-title":"J\u00a0Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib11","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/jps.24044","article-title":"Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram","volume":"103","author":"Leyva-G\u00f3mez","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/1061186X.2010.523787","article-title":"Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route","volume":"19","author":"Patel","year":"2011","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.xphs.2018.04.007_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.apsb.2014.10.005","article-title":"Solid lipid nanoparticles for nose to brain delivery of haloperidol: in\u00a0vitro drug release and pharmacokinetics evaluation","volume":"4","author":"Yasir","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.xphs.2018.04.007_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0378-5173(98)00367-6","article-title":"Evaluation of the clearance characteristics of bioadhesive systems in humans","volume":"178","author":"Soane","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0169-409X(95)00013-W","article-title":"Bioadhesive and phase-change polymers for ocular drug delivery","volume":"16","author":"Robinson","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.04.007_bib16","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jps.10371","article-title":"Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups","volume":"92","author":"Krauland","year":"2003","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib17","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejpb.2009.03.003","article-title":"Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in\u00a0vitro and in\u00a0vivo drug release","volume":"72","author":"Butoescu","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2010.05.006","article-title":"Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy","volume":"63","author":"Mahmoudi","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.04.007_bib19","first-page":"66","article-title":"Evaluation of two in situ gelling systems for ocular delivery of Moxifloxacin: in\u00a0vitro and in\u00a0vivo studies","volume":"3","author":"El-Laithy","year":"2011","journal-title":"J\u00a0Chem Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600521210","article-title":"Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices","volume":"52","author":"Higuchi","year":"1963","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.03.054","article-title":"Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels","volume":"411","author":"Asasutjarit","year":"2011","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.007_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpharm.2006.12.038","article-title":"Development of a poloxamer analogs\/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin","volume":"337","author":"Qi","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/10837450600767698","article-title":"Evaluation of carbopol-methyl cellulose based sustained-release ocular delivery system for pefloxacin mesylate using rabbit eye model","volume":"11","author":"Sultana","year":"2006","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.007_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/10717544.2011.644349","article-title":"Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa","volume":"19","author":"Samia","year":"2012","journal-title":"Drug Deliv"},{"key":"10.1016\/j.xphs.2018.04.007_bib25","first-page":"371","article-title":"Formulation and evaluation of in situ gel of diltiazem hydrochloride for nasal delivery","volume":"3","author":"Gowda","year":"2011","journal-title":"Der Pharmacia Lettre"},{"key":"10.1016\/j.xphs.2018.04.007_bib26","first-page":"245","article-title":"Evaluation of a new convulsant for anticonvulsant screening","volume":"167","author":"Banziger","year":"1967","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.xphs.2018.04.007_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.18433\/J30S31","article-title":"Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam","volume":"16","author":"Abdel-Bar","year":"2013","journal-title":"J\u00a0Pharm Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5173(93)90177-H","article-title":"Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction","volume":"93","author":"Westesen","year":"1993","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib29","first-page":"482","article-title":"Comparative study of solid lipid nanoparticles and nanostructured lipid carriers for in\u00a0vitro Paclitaxel delivery","volume":"8","author":"Swidan","year":"2016","journal-title":"J\u00a0Chem Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib30","first-page":"255","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jcis.2009.05.025","article-title":"Preparation and characterization of nanoparticles based on dextran\u2013drug conjugates","volume":"338","author":"Hornig","year":"2009","journal-title":"J\u00a0Colloid Interface Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.colsurfa.2007.08.005","article-title":"Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: nanostructured lipid carriers","volume":"315","author":"Han","year":"2008","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.xphs.2018.04.007_bib33","first-page":"62","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): occlusive effect and penetration enhancement ability","volume":"5","author":"L\u00f3pez-Garc\u00eda","year":"2015","journal-title":"J\u00a0Cosmet Dermatol Sci Appl"},{"key":"10.1016\/j.xphs.2018.04.007_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12249-011-9733-8","article-title":"Nanostructured lipid carriers (NLC) for parenteral delivery of an anticancer drug","volume":"13","author":"Chinsriwongkul","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2018.04.007_bib35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1208\/s12249-016-0621-0","article-title":"Development and optimisation of spironolactone nanoparticles for enhanced dissolution rates and stability","volume":"18","author":"Kelidar","year":"2017","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.xphs.2018.04.007_bib36","first-page":"1","article-title":"Formulation and evaluation of betamethasone sodium phosphate loaded nanoparticles for ophthalmic delivery","volume":"4","author":"Shafie","year":"2013","journal-title":"J\u00a0Clin Exp Ophthalmol"},{"key":"10.1016\/j.xphs.2018.04.007_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib38","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1517\/17425247.2014.935335","article-title":"Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals","volume":"11","author":"Aburahma","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"10.1016\/j.xphs.2018.04.007_bib39","first-page":"129","article-title":"Preparation and evaluation of montelukast sodium loaded solid lipid nanoparticles","volume":"4","author":"Priyanka","year":"2012","journal-title":"J\u00a0Young Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03639045.2015.1040414","article-title":"Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in\u00a0vivo evaluation","volume":"42","author":"Khan","year":"2016","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib41","first-page":"169","article-title":"Magnetic nanoparticles for gene and drug delivery","volume":"3","author":"McBain","year":"2008","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.xphs.2018.04.007_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5173(02)00315-0","article-title":"Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles","volume":"244","author":"Prabha","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib43","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","article-title":"A\u00a0review of poloxamer 407 pharmaceutical and pharmacological characteristics","volume":"23","author":"Dumortier","year":"2006","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1359-6446(02)02452-2","article-title":"Permeability issues in nasal drug delivery","volume":"7","author":"Arora","year":"2002","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.xphs.2018.04.007_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/03639045.2016.1225754","article-title":"Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson's disease","volume":"43","author":"Rao","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/03639045.2016.1254239","article-title":"Thermosensitive bioadhesive gels for the vaginal delivery of sildenafil citrate: in\u00a0vitro characterization and clinical evaluation in women using clomiphene citrate for induction of ovulation","volume":"43","author":"Soliman","year":"2017","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib47","first-page":"25","article-title":"In-situ gelling system: a novel approach for ocular drug delivery","volume":"2","author":"Rajoria","year":"2012","journal-title":"Am J PharmTech Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib48","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/ma00093a016","article-title":"Phase diagrams and aggregation behavior of poly(oxyethylene)-poly(oxypropylene)-poly(oxyethylene) triblock copolymers in aqueous solutions","volume":"27","author":"Wanka","year":"1994","journal-title":"Macromolecules"},{"key":"10.1016\/j.xphs.2018.04.007_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1208\/s12249-012-9893-1","article-title":"Thermoreversible nasal in situ gel of venlafaxine hydrochloride: formulation, characterization, and pharmacodynamic evaluation","volume":"14","author":"Bhandwalkar","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.xphs.2018.04.007_bib50","first-page":"159","article-title":"Development of in situ gelling and mucoadhesive mebeverine hydrochloride solution for rectal administration","volume":"11","author":"El Hady","year":"2003","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.xphs.2018.04.007_bib51","first-page":"23","article-title":"Formulation and evaluation of in-situ gelling tenoxicam liquid suppositorie","volume":"1","author":"El-Enin","year":"2013","journal-title":"J\u00a0Med Life"},{"key":"10.1016\/j.xphs.2018.04.007_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2004.09.028","article-title":"Sustained release of lidocaine from poloxamer 407 gels","volume":"288","author":"Ricci","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5173(02)00234-X","article-title":"In\u00a0vitro and in\u00a0vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate","volume":"241","author":"El-Kamel","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib54","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/bm0496965","article-title":"In situ gelling of alginate\/pluronic solutions for ophthalmic delivery of pilocarpine","volume":"5","author":"Lin","year":"2004","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.xphs.2018.04.007_bib55","series-title":"Advances in Chemistry Series","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ba-1989-0223.ch002","article-title":"Polymers in aqueous media: performance through association","author":"Kulicke","year":"1989"},{"key":"10.1016\/j.xphs.2018.04.007_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0168-3659(00)00329-1","article-title":"Carbopol\/pluronic phase change solutions for ophthalmic drug delivery","volume":"69","author":"Lin","year":"2000","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2018.04.007_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijpharm.2007.12.026","article-title":"Preparation and evaluation of self-microemulsifying drug delivery system of oridonin","volume":"355","author":"Zhang","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-5793(73)80770-7","article-title":"Biological interactions between polysaccharides and divalent cations: the egg-box model","volume":"32","author":"Grant","year":"1973","journal-title":"FEBS Lett"},{"key":"10.1016\/j.xphs.2018.04.007_bib59","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","article-title":"Mucoadhesive polymeric platforms for controlled drug delivery","volume":"71","author":"Andrews","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2018.04.007_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00003088-200140020-00001","article-title":"Bioadhesion","volume":"40","author":"Woodley","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2018.04.007_bib61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejps.2004.10.001","article-title":"Oesophageal bioadhesion of sodium alginate suspensions: 2. Suspension behaviour on oesophageal mucosa","volume":"24","author":"Richardson","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.04.007_bib62","first-page":"1191","article-title":"Sodium alginate: the wonder polymer for controlled drug delivery","volume":"2","author":"Sachan","year":"2009","journal-title":"J\u00a0Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2165\/00003088-200140120-00003","article-title":"Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations","volume":"40","author":"Thorne","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.xphs.2018.04.007_bib64","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/08958370490439597","article-title":"Translocation of inhaled ultrafine particles to the brain","volume":"16","author":"Oberd\u00f6rster","year":"2004","journal-title":"Inhal Toxicol"},{"key":"10.1016\/j.xphs.2018.04.007_bib65","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1007594602449","article-title":"BiovectorTM nanoparticles improve antinociceptive efficacy of nasal morphine","volume":"17","author":"Betbeder","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.04.007_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2006.12.014","article-title":"Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in\u00a0vitro characterisation studies","volume":"118","author":"Charlton","year":"2007","journal-title":"J\u00a0Control Release"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918302107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918302107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:23:54Z","timestamp":1758360234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918302107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0022354918302107"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.04.007","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Superparamagnetic Iron Oxide\u2013Loaded Lipid Nanocarriers Incorporated in Thermosensitive In Situ Gel for Magnetic Brain Targeting of Clonazepam","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}